ImmunoTherapy Bridge 2023
Videos
ImmunoTherapy Bridge 2023
What’s New in NSCLC & Mesothelioma Immunotherapy
FEATURING
Alessandro Morabito
- 96 views
- January 19, 2024
- 2
ImmunoTherapy Bridge 2023
Innovating Immunotherapy for Pancreatic Cancer
FEATURING
Gregory Lesinski
- 88 views
- January 19, 2024
- 2
ImmunoTherapy Bridge 2023
Immunoscore vs. Gene Signature - PRO Immunoscore
FEATURING
Jerome Galon
- 37 views
- January 11, 2024
ImmunoTherapy Bridge 2023
Best of SITC 2023 for Clinical Development and IO Trials
FEATURING
Paolo A. Ascierto
- 84 views
- January 11, 2024
- 1
ImmunoTherapy Bridge 2023
Bispecific vs. Combination Therapy - PRO Combination Therapy
FEATURING
Akash Patnaik
- 163 views
- January 10, 2024
- 2
ImmunoTherapy Bridge 2023
Bispecific vs. Combination Therapy - PRO Bispecific
FEATURING
James Gulley
- 156 views
- January 10, 2024
ImmunoTherapy Bridge 2023
Neo-Antigens vs. Alternative Antigens - PRO Neo-Antigens
FEATURING
Stephen Schoenberger
- 21 views
- January 10, 2024
ImmunoTherapy Bridge 2023
Immunotherapy for HCC: Current Status & Future Perspectives
FEATURING
Piera Federico
- 84 views
- January 10, 2024
- 1
ImmunoTherapy Bridge 2023
Activating Innate Immunity in Prostate Cancer: From Bedside-to-Bench and Back
FEATURING
Akash Patnaik
- 55 views
- January 10, 2024
ImmunoTherapy Bridge 2023
Surviving in the Lymphoma Microenvironment: A Tough Challenge for CAR T-Cells
FEATURING
Marco Ruella
- 41 views
- January 10, 2024
ImmunoTherapy Bridge 2023
Novel Insights Into the Mechanisms of Radiation-Induced Anti-Tumor Immunity
FEATURING
Sandra Demaria
- 105 views
- January 10, 2024
ImmunoTherapy Bridge 2023
New Developments in Immunotherapy for Ovarian Cancer
FEATURING
Adekunle Odunsi
- 105 views
- January 9, 2024
ImmunoTherapy Bridge 2023
Immunotherapy in GI Cancer: Current Treatment Landscape and Challenges
FEATURING
Antonio Avallone
- 200 views
- January 9, 2024
- 2
ImmunoTherapy Bridge 2023
IO Combinations in aRCC: New Achievements and Challenges
FEATURING
Roberto Iacovelli
- 44 views
- January 9, 2024
ImmunoTherapy Bridge 2023
Neoadjuvant IO: Non-Melanoma Skin Cancer
FEATURING
Neil Gross
- 117 views
- January 9, 2024
- 1
ImmunoTherapy Bridge 2023
Spatial Omics in Immunotherapy Trials: Unpacking the Challenges
FEATURING
Carlo B. Bifulco
- 50 views
- January 9, 2024
ImmunoTherapy Bridge 2023
Non-Melanoma Skin Cancers
FEATURING
Paolo A. Ascierto
- 89 views
- January 9, 2024
- 1
ImmunoTherapy Bridge 2023
Engage, Expand, Enable: Combination IO Strategy for Cold Tumors
FEATURING
James Gulley
- 50 views
- January 9, 2024
ImmunoTherapy Bridge 2023
IO in Metastatic Non-Oncogene Addicted NSCLC: Consolidated Options to Cover the Unmet Need
FEATURING
Alessandro Morabito
- 85 views
- January 9, 2024
ImmunoTherapy Bridge 2023
How Immunotherapy Changed the Treatment Story for Endometrial and Cervical Cancers
FEATURING
Michele Bartoletti
- 81 views
- January 9, 2024
ImmunoTherapy Bridge 2023
Updates on Radiation and Immunotherapy
FEATURING
Silvia Formenti
- 56 views
- January 9, 2024
- 1